Medications

FDA approves Dupixent for chronic obstructive pulmonary disease

The U.S. Food and Drug Administration has approved Regeneron's Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic ...

Cardiology

Systemic immune-inflammation index tied to mortality in CKD

There is a J-shaped association between systemic immune-inflammation index (SII) levels and all-cause mortality in patients with chronic kidney disease (CKD), according to a study published online Sept. 10 in Immunity, Inflammation ...

page 10 from 40